TSX:BLU (Canada)  
BELLUS Health Inc logo

BELLUS Health Inc

C$ 14.58 (+1.89%) Oct 4
P/E:
At Loss
P/B:
4.61
Market Cap:
C$ 1.83B ($ 1.35B)
Enterprise V:
C$ 1.53B ($ 1.13B)
Volume:
142.50K
Avg Vol (2M):
249.91K
Also Trade In:
Volume:
142.50K
Market Cap C$:
1.83B
Market Cap $:
1.35B
PE Ratio:
At Loss
Avg Vol (2-Month):
249.91K
Enterprise Value C$:
1.53B
Enterprise Value $:
1.13B
PB Ratio:
4.61
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.
Name Current Vs Industry Vs History
Cash-To-Debt 305.76
Equity-to-Asset 0.93
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 40.31
Distress
Grey
Safe
Beneish M-Score -2.59
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 56.37
9-Day RSI 52.45
14-Day RSI 51.67
6-1 Month Momentum % 64.35
12-1 Month Momentum % 102.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.16
Quick Ratio 12.16
Cash Ratio 11.53
Days Sales Outstanding 10524.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -34.6

Financials (Next Earnings Date:2022-11-10 Est.)

TSX:BLU's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0.02
EPS (TTM) (C$) -0.992
Beta -0.72
Volatility % 55.87
14-Day RSI 51.67
14-Day ATR (C$) 0.772764
20-Day SMA (C$) 14.5165
12-1 Month Momentum % 102.51
52-Week Range (C$) 6.3 - 16.24
Shares Outstanding (Mil) 125.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BELLUS Health Inc Filings

Document Form Filing Date
No Filing Data

BELLUS Health Inc Analysis

Share your research